These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

448 related items for PubMed ID: 16731853

  • 1. The experimental type 2 diabetes therapy glycogen phosphorylase inhibition can impair aerobic muscle function during prolonged contraction.
    Baker DJ, Greenhaff PL, MacInnes A, Timmons JA.
    Diabetes; 2006 Jun; 55(6):1855-61. PubMed ID: 16731853
    [Abstract] [Full Text] [Related]

  • 2. Glycogen phosphorylase inhibition in type 2 diabetes therapy: a systematic evaluation of metabolic and functional effects in rat skeletal muscle.
    Baker DJ, Timmons JA, Greenhaff PL.
    Diabetes; 2005 Aug; 54(8):2453-9. PubMed ID: 16046314
    [Abstract] [Full Text] [Related]

  • 3. Sensitivity of glycogen phosphorylase isoforms to indole site inhibitors is markedly dependent on the activation state of the enzyme.
    Freeman S, Bartlett JB, Convey G, Hardern I, Teague JL, Loxham SJ, Allen JM, Poucher SM, Charles AD.
    Br J Pharmacol; 2006 Nov; 149(6):775-85. PubMed ID: 17016495
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of the interaction between protein phosphatase 1 glycogen-targeting subunit and glycogen phosphorylase increases glycogen synthesis in primary rat hepatocytes.
    Zibrova D, Grempler R, Streicher R, Kauschke SG.
    Biochem J; 2008 Jun 01; 412(2):359-66. PubMed ID: 18298402
    [Abstract] [Full Text] [Related]

  • 5. Effect of angiotensin-converting enzyme inhibition on skeletal muscle oxidative function and exercise capacity in streptozotocin-induced diabetic rats.
    Rouyer O, Zoll J, Daussin F, Damgé C, Helms P, Talha S, Rasseneur L, Piquard F, Geny B.
    Exp Physiol; 2007 Nov 01; 92(6):1047-56. PubMed ID: 17675412
    [Abstract] [Full Text] [Related]

  • 6. Glutathione-dependent reduction of arsenate by glycogen phosphorylase responsiveness to endogenous and xenobiotic inhibitors.
    Gregus Z, Németi B.
    Toxicol Sci; 2007 Nov 01; 100(1):44-53. PubMed ID: 17693424
    [Abstract] [Full Text] [Related]

  • 7. Effects in skeletal muscle.
    Young A.
    Adv Pharmacol; 2005 Nov 01; 52():209-28. PubMed ID: 16492548
    [Abstract] [Full Text] [Related]

  • 8. Local nitric oxide synthase inhibition reduces skeletal muscle glucose uptake but not capillary blood flow during in situ muscle contraction in rats.
    Ross RM, Wadley GD, Clark MG, Rattigan S, McConell GK.
    Diabetes; 2007 Dec 01; 56(12):2885-92. PubMed ID: 17881613
    [Abstract] [Full Text] [Related]

  • 9. Contraction-mediated glycogenolysis in mouse skeletal muscle lacking creatine kinase: the role of phosphorylase b activation.
    Katz A, Andersson DC, Yu J, Norman B, Sandstrom ME, Wieringa B, Westerblad H.
    J Physiol; 2003 Dec 01; 553(Pt 2):523-31. PubMed ID: 12963789
    [Abstract] [Full Text] [Related]

  • 10. Effect of impaired glucose uptake on postexercise glycogen repletion in skeletal muscles of insulin-treated streptozotocin-diabetic fasted rats.
    Ferreira LD, Xu D, Palmer TN, Fournier PA.
    Metabolism; 2005 Nov 01; 54(11):1420-7. PubMed ID: 16253628
    [Abstract] [Full Text] [Related]

  • 11. Hepatic glycogen breakdown is implicated in the maintenance of plasma mannose concentration.
    Taguchi T, Yamashita E, Mizutani T, Nakajima H, Yabuuchi M, Asano N, Miwa I.
    Am J Physiol Endocrinol Metab; 2005 Mar 01; 288(3):E534-40. PubMed ID: 15536204
    [Abstract] [Full Text] [Related]

  • 12. Effects of hyperglycemia on hepatic gluconeogenic flux during glycogen phosphorylase inhibition in the conscious dog.
    Edgerton DS, Cardin S, Neal D, Farmer B, Lautz M, Pan C, Cherrington AD.
    Am J Physiol Endocrinol Metab; 2004 Apr 01; 286(4):E510-22. PubMed ID: 14644767
    [Abstract] [Full Text] [Related]

  • 13. The content of glycogen phosphorylase and glycogen in preparations of sarcoplasmic reticulum-glycogenolytic complex is enhanced in diabetic rat skeletal muscle.
    Garduño E, Nogues M, Merino JM, Gutiérrez-Merino C, Henao F.
    Diabetologia; 2001 Oct 01; 44(10):1238-46. PubMed ID: 11692172
    [Abstract] [Full Text] [Related]

  • 14. Prolonged inhibition of glycogen phosphorylase in livers of Zucker Diabetic Fatty rats models human glycogen storage diseases.
    Floettmann E, Gregory L, Teague J, Myatt J, Hammond C, Poucher SM, Jones HB.
    Toxicol Pathol; 2010 Apr 01; 38(3):393-401. PubMed ID: 20215584
    [Abstract] [Full Text] [Related]

  • 15. Acyl ureas as human liver glycogen phosphorylase inhibitors for the treatment of type 2 diabetes.
    Klabunde T, Wendt KU, Kadereit D, Brachvogel V, Burger HJ, Herling AW, Oikonomakos NG, Kosmopoulou MN, Schmoll D, Sarubbi E, von Roedern E, Schönafinger K, Defossa E.
    J Med Chem; 2005 Oct 06; 48(20):6178-93. PubMed ID: 16190745
    [Abstract] [Full Text] [Related]

  • 16. Synthesis of a C-glucosylated cyclopropylamide and evaluation as a glycogen phosphorylase inhibitor.
    Bertus P, Szymoniak J, Jeanneau E, Docsa T, Gergely P, Praly JP, Vidal S.
    Bioorg Med Chem Lett; 2008 Sep 01; 18(17):4774-8. PubMed ID: 18701279
    [Abstract] [Full Text] [Related]

  • 17. Effect of alpha-tocopherol on glucose uptake and contractility in rat skeletal muscle.
    Haidara MA, Ibrahim IM, Al-Tuwaijri AS, Awadalla SA, Yaseen H.
    Med Sci Monit; 2003 May 01; 9(5):BR174-7. PubMed ID: 12761442
    [Abstract] [Full Text] [Related]

  • 18. Dietary glycemic index influences lipid oxidation but not muscle or liver glycogen oxidation during exercise.
    Stevenson EJ, Thelwall PE, Thomas K, Smith F, Brand-Miller J, Trenell MI.
    Am J Physiol Endocrinol Metab; 2009 May 01; 296(5):E1140-7. PubMed ID: 19223653
    [Abstract] [Full Text] [Related]

  • 19. Brain glycogen and its role in supporting glutamate and GABA homeostasis in a type 2 diabetes rat model.
    Sickmann HM, Waagepetersen HS, Schousboe A, Benie AJ, Bouman SD.
    Neurochem Int; 2012 Feb 01; 60(3):267-75. PubMed ID: 22244844
    [Abstract] [Full Text] [Related]

  • 20. FR258900, a novel glycogen phosphorylase inhibitor isolated from Fungus No. 138354. II. Anti-hyperglycemic effects in diabetic animal models.
    Furukawa S, Murakami K, Nishikawa M, Nakayama O, Hino M.
    J Antibiot (Tokyo); 2005 Aug 01; 58(8):503-6. PubMed ID: 16266121
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.